RebateManufacturer Discount, Volume Concession
A retrospective payment from a manufacturer to a payer, typically a percentage of price or based on utilisation volume, reducing true net cost.
Terms for how medicine prices are set and negotiated and how patients gain access to new treatments.
A retrospective payment from a manufacturer to a payer, typically a percentage of price or based on utilisation volume, reducing true net cost.
The specific group of countries whose drug prices are used as the reference point when a country sets its own prices.
An arrangement distributing the financial or clinical uncertainty of a new treatment's real-world performance between manufacturer and payer, often linked to outcomes.